Probiotics as Complementary Treatment for Metabolic Disorders

다국어 초록 (Multilingual Abstract)

Over the past decade, growing evidence has established the gut microbiota as one of the most important determinants of metabolic disorders such as obesity and type 2 diabetes. Indeed, obesogenic diet can drastically alter bacterial populations (i.e., dysbiosis) leading to activation of pro-inflammatory mechanisms and metabolic endotoxemia, therefore promoting insulin resistance and cardiometabolic disorders. To counteract these deleterious effects, probiotic strains have been developed with the aim of reshaping the microbiome to improve gut health. In this review, we focus on benefits of widely used probiotics describing their potential mechanisms of action, especially their ability to decrease metabolic endotoxemia by restoring the disrupted intestinal mucosal barrier. We also discuss the perspective of using new bacterial strains such as butyrate-producing bacteria and the mucolytic Akkermansia muciniphila, as well as the use of prebiotics to enhance the functionality of probiotics. Finally, this review introduces the notion of genetically engineered bacterial strains specifically developed to deliver anti-inflammatory molecules to the gut.

참고문헌 (Reference)

1 Neyrinck AM, "Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice" 2 : e28-, 2012

2 Parnell JA, "Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults" 89 : 1751-1759, 2009

3 Ahn HY, "The triglyceride-lowering effect of supplementation with dual probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032: Reduction of fasting plasma lysophosphatidylcholines in nondiabetic and hypertriglyceridemic subjects" 25 : 724-733, 2015

4 Smith PM, "The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis" 341 : 569-573, 2013

5 McNulty NP, "The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins" 3 : 2011

6 Backhed F, "The gut microbiota as an environmental factor that regulates fat storage" 101 : 15718-15723, 2004

7 Hariri M, "The effect of probiotic soy milk and soy milk on anthropometric measures and blood pressure in patients with type II diabetes mellitus: a randomized double-blind clinical trial" 11 (11): 74-80, 2015

8 Kailasapathy K, "Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp" 78 : 80-88, 2000

9 Park DY, "Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity" 8 : e59470-, 2013

10 Verdam FJ, "Small intestinal alterations in severely obese hyperglycemic subjects" 96 : E379-E383, 2011

11 den Besten G, "Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARgamma-dependent switch from lipogenesis to fat oxidation" 64 : 2398-2408, 2015

12 Kim MH, "Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice" 145 : 396.e1-406.e10, 2013

13 Cani PD, "Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia" 50 : 2374-2383, 2007

14 Everard A, "Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice" 5 : e01011-e01014, 2014

15 Felice C, "Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases" 41 : 26-38, 2015

16 Laukoetter MG, "Regulation of the intestinal epithelial barrier by the apical junctional complex" 22 : 85-89, 2006

17 Luck H, "Regulation of obesity-related insulin resistance with gut anti-inflammatory agents" 21 : 527-542, 2015

18 O’Shea EF, "Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid" 152 : 189-205, 2012

19 Gareau MG, "Probiotics and the gut microbiota in intestinal health and disease" 7 : 503-514, 2010

20 Yoo SR, "Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity" 21 : 2571-2578, 2013

21 Hulston CJ, "Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects" 113 : 596-602, 2015

22 Neyrinck AM, "Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice" 6 : 2011

23 Stenman LK, "Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice" 5 : 437-445, 2014

24 Minami J, "Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial" 4 : e17-, 2015

25 Bindels LB, "Non digestible oligosaccharides modulate the gut microbiota to control the development of leukemia and associated cachexia in mice" 10 : 2015

26 Stéphanie Dudonné, "Modulatory effects of a cranberry extract co-supplementation with Bacillus subtilis CU1 probiotic on phenolic compounds bioavailability and gut microbiota composition in high-fat diet-fed mice" Elsevier BV 3 (3): 89-100, 2015

27 Wang J, "Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice" 9 : 1-15, 2015

28 Khan MT, "Microbial modulation of insulin sensitivity" 20 : 753-760, 2014

29 Ritze Y, "Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice" 9 : e80169-, 2014

30 Rousseaux C, "Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors" 13 : 35-37, 2007

31 Turner JR, "Intestinal mucosal barrier function in health and disease" 9 : 799-809, 2009

32 Cousin FJ, "Interactions between probiotic dairy propionibacteria and the intestinal epithelium" 8 : 216-226, 2012

33 Chen Z, "Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity" 124 : 3391-3406, 2014

34 E Quévrain, "Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii , a commensal bacterium deficient in Crohn’s disease" BMJ 65 (65): 415-425, 2016

35 Kau AL, "Human nutrition, the gut microbiome and the immune system" 474 : 327-336, 2011

36 Moya-Perez A, "Hepatic molecular responses to Bifidobacterium pseudocatenulatum CECT 7765 in a mouse model of diet-induced obesity" 24 : 57-64, 2014

37 Delzenne NM, "Gut microbiota and metabolic disorders: how prebiotic can work?" 109 (109): S81-S85, 2013

38 허규연, "Gut Microbiota and Metabolic Disorders" 대한당뇨병학회 39 (39): 198-203, 2015

39 Thomas LV, "Exploring the influence of the gut microbiota and probiotics on health: a symposium report" 112 (112): S1-S18, 2014

40 Hill C, "Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic" 11 : 506-514, 2014

41 Duan FF, "Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes" 64 : 1794-1803, 2015

42 Oksaharju A, "Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet" 110 : 77-85, 2013

43 de Moreno de LeBlanc A, "Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications" 20 : 16518-16528, 2014

44 Sanchez M, "Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women" 111 : 1507-1519, 2014

45 Wu CC, "Effect of Lactobacillus plantarum strain K21 on high-fat diet-fed obese mice" 2015 : 391767-, 2015

46 David LA, "Diet rapidly and reproducibly alters the human gut microbiome" 505 : 559-563, 2014

47 de Moreno de LeBlanc A, "Current review of genetically modified lactic acid bacteria for the prevention and treatment of colitis using murine models" 2015 : 146972-, 2015

48 Everard A, "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity" 110 : 9066-9071, 2013

49 De Vuyst L, "Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production" 149 : 73-80, 2011

50 Falony G, "Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose" 72 : 7835-7841, 2006

51 Veiga P, "Changes of the human gut microbiome induced by a fermented milk product" 4 : 6328-, 2014

52 Cani PD, "Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice" 57 : 1470-1481, 2008

53 Champagne CP, "Challenges in the addition of probiotic cultures to foods" 45 : 61-84, 2005

54 Eeckhaut V, "Butyricicoccus pullicaecorum in inflammatory bowel disease" 62 : 1745-1752, 2013

55 Endo H, "Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis" 8 : e63388-, 2013

56 Yadav H, "Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion" 288 : 25088-25097, 2013

57 Nabavi S, "Asghari-Jafarabadi M. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease" 97 : 7386-7393, 2014

58 Van den Abbeele P, "Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats" 13 : 2667-2680, 2011

59 Kang JH, "Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice" 8 : e54617-, 2013

60 Turnbaugh PJ, "An obesity-associated gut microbiome with increased capacity for energy harvest" 444 : 1027-1031, 2006